BiDil smoke and mirrors

I’ve said from the beginning that BiDil is essentially two generics combined into an expensive brand name drug. Well the sales are showing that this approach isn’t working:

As the WSJ reported earlier this year, groups including the American Heart Association and the American College of Cardiology say there’s no evidence that prescribing BiDil works any better than prescribing both of its constituent generics, isosorbide dinitrate and hydralazine. Yet BiDil costs insurers between $1,400 and $2,800 per year, while the generics can cost less than $100.

Related posts:

1. TriCor, smoke and mirrors
2. BiDil sales "suck"
3. Racist not to cover BiDil?
4. The Angry Pharmacist on the Medicare donut-hole
5. Health care workers smoke at a greater rate than the public
6. Why did BiDil fail?
7. The physician who disputes second-hand smoke claims

  Follow on Twitter   Subscribe

Tagged as: heart, patient